Drug Type Monoclonal antibody |
Synonyms Anti-CKAP4 mAb (Osaka University), CKAP4-targeted Cancer Therapy (Osaka University) |
Target |
Mechanism CKAP4 inhibitors(cytoskeleton associated protein 4 inhibitors) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pancreatic Cancer | Preclinical | JP | 08 Aug 2024 |